1. The influence of non-steroidal anti-inflammatory drugs on the gut microbiome 
M.A.M. Rogers, D.M. Aronoff 
Clinical Microbiology and Infection 
Volume 22, Issue 2, Pages 178.e1-178.e9 (February 2016)
DOI: /j.cmi
Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

2. Fig. 1
Gut bacterial operational taxonomic units (OTUs) for participants using only one medication vs. participants using no medication.
Clinical Microbiology and Infection  , 178.e1-178.e9DOI: ( /j.cmi )
Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

3. Fig. 2
Prevalence of gut bacterial families for participants using only non-steroidal anti-inflammatory drugs (NSAIDs) vs. participants not using medication.
Clinical Microbiology and Infection  , 178.e1-178.e9DOI: ( /j.cmi )
Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

4. Fig. 3
Receiver operating characteristic curves for participants using (a) non-steroidal anti-inflammatory drugs or (b) naproxen, showing discrimination by age, gender, and microbiome data. AUC, area under the curve.
Clinical Microbiology and Infection  , 178.e1-178.e9DOI: ( /j.cmi )
Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

5. Fig. 4
Heat-map for bacterial families, showing differences in relative abundance by medication use.
Clinical Microbiology and Infection  , 178.e1-178.e9DOI: ( /j.cmi )
Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

6. Fig. 5
Principal component analysis biplot of bacteria to distinguish ibuprofen users from naproxen users.
Clinical Microbiology and Infection  , 178.e1-178.e9DOI: ( /j.cmi )
Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

7. Fig. 6
Relative abundance of bacterial operational taxonomic units (OTUs) by medication type. Abx, antibiotic; ATD, antidepressant; H2R, H2 receptor antagonist; Lax, laxative; NSAID, non-steroidal anti-inflammatory drug; PPI, proton-pump inhibitor.
Clinical Microbiology and Infection  , 178.e1-178.e9DOI: ( /j.cmi )
Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions